MedTrace Logo

CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)

NCT07643077 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2026-06-11

No results posted yet for this study

Summary

The effect of latanoprost with preservatives on the ocular surface microbiome

Conditions

Interventions

DRUG

Latanoprost with preservatives (BAK) once per day for at least 6 months period

Existing studies have primarily assessed these differences by comparing treated glaucoma patients to healthy controls, rather than examining changes within the same individuals over time.

Sponsors & Collaborators

  • University of Ioannina

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-20
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07643077 on ClinicalTrials.gov